Get all your news in one place.
100's of premium titles.
One app.
Start reading
Salon
Salon
Science
Charlotte Kilpatrick

Big Pharma won't let the vaccine out

Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. JOHN THYS/POOL/AFP via Getty Images

After months of stalling debate, World Trade Organization member states appear to have finally reached a consensus in the stalemate negotiations for a COVID-19 intellectual property waiver that is a watered-down version of the one proposed by India and South Africa 18 months ago. 

The original waiver called for the temporary suspension of all intellectual property rights — including, patents, copyrights, trademarks, and trade secrets — that are necessary to reproduce vaccines, diagnostic tests, and therapies for COVID-19. International organizations including Oxfam and Doctors Without Borders supported the waiver in its original form to increase access to medicine and prevent a new variant from developing in areas of low immunity.  

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.